Granulocyte macrophage-colony-stimulating factor mouthwashes heal oral ulcers during head and neck radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 41, Issue 4, 1998, Pages 747-754

  Rovirosa, Angeles ^a   Ferre, Jorge ^b   Biete, Albert ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

GM CSF; Head and neck carcinoma; Radiation mucositis

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; AGED; ANALGESIA; ANOREXIA; ARTICLE; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; HEAD AND NECK TUMOR; HUMAN; MAJOR CLINICAL STUDY; MOUTH ULCER; MOUTHWASH; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIATION INJURY; RADIATION RESPONSE; TREATMENT INDICATION; TREATMENT OUTCOME; WEIGHT REDUCTION;

AGED; CASE-CONTROL STUDIES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEAD AND NECK NEOPLASMS; HUMANS; MIDDLE AGED; MOUTHWASHES; ORAL ULCER; RADIATION INJURIES; RADIOTHERAPY DOSAGE;

EID: 0031804490     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00109-6     Document Type: Article

References (45)

1. Kaanders J.H.A.M., Ang K.K. Early reactions and dose-limiting factors in radiotherapy. Semin. Radiat. Oncol. 4:1994;55-67.
2. Parsons J.T. The effect of radiation on normal tissues of head and neck. Million R.R., Cassissi N.J. Management of head and neck cancer. A multidisciplinary approach. 2nd ed. 1994;245-247 JB Lippincott, Philadelphia, PA.
3. Smichmidt-Ullrich R.K., Johnson C., Wazer D.E., Masko G., Chasin W.D., Karmody C.S. Accelerated superfractionated irradiation for advanced carcinoma of head and neck Concomitant boost technique . Int. J. Radiat. Oncol. Biol. Phys. 21:1991;563-568.
4. Horiot J.C., Le Fur R., N'Guyen T., Chenal C., Schraub S., Alfonsi S., Gardani G., Van Den Bogaert S., Danczak S., Bolla M., Van Glabbeke M., De Pauw M. Hyperfractionation versus conventional fractionation in oropharingeal carcinoma Final analysis of a randomized trial of the EORTC cooperative group of radiotherapy . Radiother. Oncol. 25:1992;231-241.
5. Geara F., Peters L., Ang K., Garden A.S., Tucker S.L., Levy L.B., Brown B.W. Comparison between normal tissue reactions and local tumor control in head and neck cancer patients treated by definitive radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 35:1996;455-462.
6. Peracchia G., Salti C. Radiotherapy with thrice-a-day fractionation in a short overall time Clinical experiences . Int. J. Radiat. Oncol. Biol. Phys. 7:1981;99.
7. Duncan W., MacDougall H., Kerr G.R., Downing D. Adverse effect of treatment gaps in the outcome of radiotherapy for laryngeal cancer. Radiother. Oncol. 41:1996;203-207.
8. Rodriguez A., Calvo E., Soria P., Sánchez C., Alonso O., Vega M.J., Nieto A., Solbes R., Soler J.J. Fluconazol en la profilaxis de la mucositis oral radioinducida Estudio preliminar . Oncologia. 19:1996;286-289.
9. Amdur R.J., Parsons J.T., Mendenhall W.M., Million R.R., Cassisi N.J. Split-course versus continuous-course irradiation in the postoperative setting for squamous cell carcinoma of head and neck. Int. J. Radiat. Oncol. Biol. Phys. 17:1989;279-285.
10. Conley B., Jacobs M., Suntharalingan M., Zacharski D., Ord R.A., Gray W., Aisner J. The role of paclitaxel/carboplatin and concurrent radiotherapy in unresectable head and neck Recent findings . Semin. Radiat. Oncol. (Suppl. 1):1997;39-41.
11. Knee R., Fields R.S., Peters L.J. Concomitant boost radiotherapy for advanced squamous cell carcinoma of the head and neck. Radiother. Oncol. 4:1985;1-7.
12. Maciejewski B., Preuss-Bayer G., Trott K.R. The influence of number of fractions and of overall treatment time on local control and late complications rate in squamous cell carcinoma of the larynx. Int. J. Radiat. Oncol. Biol. Phys. 9:1983;321-328.
13. Maciejewski B., Withers H.R., Taylor J.M.G., Hliniak A. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx Tumor dose response and repopulation . Int. J. Radiat. Oncol. Biol. Phys. 16:1989;831-843.
14. Overgaard J., Hjelm-Hansen C., Johansen M., Andersen A.P. Comparison of conventional and split course radiotherapy as primary treatment in carcinoma of the larynx. Acta Oncol. 27:1988;147-152.
15. Parsons J.T., Bova F.J., Million R.R. A re-evaluation of split-course technique for squamous carcinoma of the head and neck. Int. J. Radiat. Oncol. Biol. Phys. 6:1980;1645-1652.
16. Taylor J.M.G., Withers H.R., Mendenhall W.M. Dose-time considerations of head and neck squamous cell carcinomas treated with irradiation. Radiother. Oncol. 17:1990;95-102.
17. Pajak T.F., Laramore G.E., Marcial V.A. Elapsed treatment days - a critical item for radiotherapy quality control review in head and neck trials. Int. J. Radiat. Oncol. Biol. Phys. 20:1991;13-20.
18. Van den Bogaert W.V., Van der Leest A.V., Rijnders A., Delaere P., Thames H., Van der Shueren E. Does tumor control decrease by prolonging overall treatment time or interrupting treatment in laryngeal carcinoma? Radiother. Oncol. 36:1995;177-182.
19. Hansen O., Overgaard J., Hansen H.S., Overgaard M., Hoyer M., Jorgensen K.E., Bastholt L., Berthelsen A. Importance of overall treatment time for the outcome of radiotherapy of advanced head and neck carcinoma dependency of tumor differentiation . Radiother. Oncol. 43:1997;47-51.
20. Nishimura Y., Nagata Y., Okajima K., Mitsumori M., Hiraoka M., Masunaga S., Ono K., Shoji K., Kojima H. Radiation therapy for T1,2 gotic carcinoma Impact of overall treatment time on local control . Radiother. Oncol. 40:1996;225-232.
21. Ferre J., Biete A., Pina J., Rovirosa A., Conill C. Prevención de la mucositis bucal inducida por radioterapia de cabeza y cuello. Avances Odontoestomatología. 12:1996;187-193.
22. Ferre J., Rovirosa A., Bondia M., Ferrer F., Biete A. Prevention oral mucositis in head and neck radiotherapy. EJC. 31A:(Suppl. 5):1995;179.
23. Bradford C.R., Ong E.L.C., Hendrick D.J., Paton W.N. Use of colony stimulating factors for the treatment of drug-induced agranulocytosis. Br. J. Haematol. 84:1993;182-186.
24. Neumanaitis J., Rosenfeld C.S., Ash R., Freedman M.H., Deeg H.J., Appelbaum F., Singer J.W., Flomenberg N., Daton W., Elfenbein G.J., Rifkin R., Rubin A., Agosti J., Hayes F.A., Holcenberg J., Shadduck R.K. Phase II randomized double-blind placebo-controlled trial of rh GM-CSF following allogeneic bone marrow transplantation. Bone Marrow Transplant. 15:1995;949-954.
25. Gordon B., Spandinger A., Hodges E., Ruby E., Stamley R., Coccia P. Effect of granulocyte-macrophage colony stimulating factor on oral mucositis after hematopoietic stem-cell transplantation. J. Clin. Oncol. 12:1994;1917-1922.
26. Chi K.K., Chen C.H., Chan W.K., Chow K.C., Chen S.Y., Yen S.H., Chao J.Y., Chang C.Y., Chen K.Y. Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer after cisplatin, fluorouracil and leucovorin chemotherapy. J. Clin. Oncol. 13:1995;2620-2628.
27. Bennet N.T., Shult G.S. Growth factors and wound healing Biochemical properties of growth factors and their receptors . Am. J. Surg. 165:1993;728-737.
28. Braunstein S., Kaplan G., Gottielb A.B., Schwartz M. GM-CSF activates regenerative epidermal growth and stimulates keratinocyte proliferation in human skin in vivo. J. Invest. Dermatol. 103:1994;601-604.
29. Da Costa R.M., Aniceto T., Jesus F.M., Mendes M. Quick healing of leg ulcers after molgramostim. Lancet. 344:1994;481-482.
30. Davidson J.M., Broadley K.N. Manipulation of the wound healing process with fibroblast growth factor. Ann. NY. Acad. Sci. 638:1991;307-315.
31. Jyung R.W., Wu L., Pierce G.F., Mustoe T.A. Granulocite macrophage colony-stimulating factor and granulocyte colony stimulating factor differential action on incisional wound healing . Surgery. 115:1994;325-334.
32. Robson M., Kucukcelebi A., Carp S.S., Hayward P.S., Huy P.S., Cowan W.T., Ko F., Cooper D. Effects of granulocyte-macrophage colony-stimulating factor on wound contraction. Eur. J. Clin. Microbiol. Infect. Dis. 13:(Suppl. 2):1994;41-46.
33. Rubbia L., Sappino A.C., Gabbiani G. Locally applied GM-CSF induces the accumulation of alpha-smooth muscle actin containing myofibroblasts. Virchows Arch. B. Cell. Pathol. Oncol. Mol. Pathol. 60:1991;73-82.
34. Schiliepphake H., Neukam F.W., Lohr A., Hutmacher D. The use of basic fibroblast growth factor (bFGF) for enhancement of bone ingrowth into pyrolized bovine bone. Int. J. Oral Maxillofac. Surg. 24:1995;181-186.
35. Wardley A.M., Scarffe J.H. Role of granulocyte-macrophage colony-stimulating factor in chemoradiotherapy-induced oral mucositis. J. Clin Oncol. 14:1996;1741-1744.
36. Bussolino F., Ziche M., Wang J.M., Alessi D., Morbidelli L., Cremona D., Bossia A., Marchisio P.C., Mantovani A. In vitro and in vivo activation of endothelial cells by colony stimulating factors. J. Clin. Invest. 87:1991;986-995.
37. Kapplan G., Walsh G., Guido L.S., Meyn P., Burkhardt R.A., Abalos R.M., Barker J., Frinft P.A., Fajardo T.T., Celona R. Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating factor Langerhans cell recruitment, keratinocyte growth, and enhancement of wound healing . J. Exp. Med. 175:1992;1717-1728.
38. Ovilla-Martinez R., Rubio M., Borbolla J.R., Glozale-Laaven J.E. GM-CSF mouthwashes as treatment for mucositis in BMT patients. Blood. 84:1994;717.
39. Ferre, J.; Rovirosa, A.; Biete, A. Efecto del Filgastrim (r-met HuG-CSF) sobre la mucositis oral radioinducida en pacientes con neoplasia de cabeza y cuello. Libro de comunicaciones del III Congreso de la Sociedad Española de Medicina Oral. 1996; 13.
40. Robson A., Kucukcelebi S.S., Carp P.G., Hayward P.S., Hui W.T., Covan F., Cooper D.M. Effects of granulocyte-macrophage colony stimulating factor on wound contraction. Eur. J. Clin. Microbiol. Infect. Dis. 2:(Suppl.):1994;41-46.
41. Masucci G. New clinical applications of granulocyte-macrophage colony-stimulating factor. Med. Oncol. 13:1996;149-154.
42. Masucci, G.; Fernberg, J. O.; Höglun-Ersin, L.; Lewensohn, R.; Strader, H. Beneficial treatment of radiotherapy induced mucositis with rH-GM-CSF in patients with tumors of the oral cavity/oropharynx. In: Sixth International Congress on Anti-cancer Treatment, 6-9 February, 1996, abstr. 167, p. 83.
43. Throuvalas N., Antonadou D., Pullizi M., Sarris G. Evaluation of efficacy and safety of GM-CSF in the propylaxis of mucositis in patients in patients with head and neck cancer treated with RT. Eur. J. Cancer. 41A:(Suppl. 7):1997;431.
44. Kannan V., Bapsy P.P., Anantha N., Doval D.C., Vaithianathan H., Banumathy G., Reddy K.B., Kuwaraswamy S.V., Shenoy A.M. Efficacy and safety of granulocyte macrophage-colony stimulating factor (GM-CSF) on the frequency and severity of radiation mucositis in patients with head and neck carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 37:1997;1005-1010.
45. De la Torre A., Regueiro C.A., Valcarcel F.J. Granulocyte-macrophage colony-stimulating factor mouthwashes improve radiation induced mucositis in AIDS patients. Radiother. Oncol. 43:1997;229-230.